Home
About
Overview
Sharing Data
ORCID
Help
History (58)
Group IB Phospholipases A2
Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes.
Erythroxylaceae
A cost effective base-matching assay with low backgrounds.
Risk management in therapeutics: when the patient becomes the last line of defense.
See All 58 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Risk management in therapeutics: when the patient becomes the last line of defense.
Gurwitz JH, Andrade SE. Risk management in therapeutics: when the patient becomes the last line of defense. Pharmacoepidemiol Drug Saf. 2002 Dec; 11(8):637-9.
View in:
PubMed
subject areas
Humans
Risk Management
Therapeutics